On the contrary, Velten et al. [90] indicated that pretreatment with synthetic TLR9 ligand 1668-thioate attenuated cardiac hypertrophy following pressure overload and delayed the cardiac function loss, which resulted in a prolonged preservation of left ventricular function. This evidence concerns the gene TLR9 and cardiac hypertrophy.